Engineered bacteria launch and control an oncolytic virus
Nature Biomedical Engineering – CAPPSID relies on an engineered S. typhimurium to act as a synthetic ‘capsid’ to transcribe and deliver viral RNA inside cancer cells, launching a virus…
Related Articles
The Economic History Review | EHS Journal | Wiley Online Library
How do famines shape the health of survivors? We examine the long-term impact of the Great Irish Famine (1845–52) on human stature, distinguishing between adverse…
Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study
AbstractBackground and Aims. Increasing evidence suggests that COVID-19 survivors experience long-term cardiovascular complications possibly through develo
Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection
Blood Cancer Journal – Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer’s disease
Nature Communications – Olfactory deficits occur early in Alzheimer’s disease (AD). Here, the authors identify that loss of locus coeruleus axons in the olfactory bulb…
Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial
Nature Medicine – A phase 1/2 trial of dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis, administered by bilateral intrathalamic, cisterna magna and intrathecal delivery found…
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results
Nature Medicine – In the final analysis of a phase 1 trial evaluating a lymph node-targeting mutant KRAS peptide vaccine combined with CpG in the…
Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms
Blood Cancer Journal – Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests
Nature Reviews Clinical Oncology – Liquid biopsy-based tests have demonstrated potential as a minimally invasive and broadly applicable approach to simultaneously screen individuals for multiple…
Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms
Blood Cancer Journal – Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms